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n mammalian cells, most membrane proteins are inserted
cotranslationally into the ER membrane at sites termed
translocons. Although each translocon forms an aqueous
pore, the permeability barrier of the membrane is maintained
during integration, even when the otherwise tight ribosome–
translocon seal is opened to allow the cytoplasmic domain
of a nascent protein to enter the cytosol. To identify the
mechanism by which membrane integrity is preserved,
nascent chain exposure to each side of the membrane was
determined at different stages of integration by collisional
quenching of a ﬂuorescent probe in the nascent chain.
Comparing integration intermediates prepared with intact,
empty, or BiP-loaded microsomes revealed that the lumenal
 
end of the translocon pore is closed by BiP in an ATP-
dependent process before the opening of the cytoplasmic
ribosome–translocon seal during integration. This BiP function
I
 
is distinct from its previously identiﬁed role in closing
ribosome-free, empty translocons because of the presence
of the ribosome at the translocon and the nascent membrane
protein that extends through the translocon pore and into
the lumen during integration. Therefore, BiP is a key compo-
nent in a sophisticated mechanism that selectively closes the
lumenal end of some, but not all, translocons occupied by a
nascent chain. By using collisional quenchers of different
sizes, the large internal diameter of the ribosome-bound
aqueous translocon pore was found to contract when BiP
was required to seal the pore during integration. Therefore,
closure of the pore involves substantial conformational
changes in the translocon that are coupled to a complex
sequence of structural rearrangements on both sides of the
ER membrane involving the ribosome and BiP.
 
Introduction
 
Nearly all membrane proteins in a mammalian cell are in-
serted into the membrane of the ER in a cotranslational
manner at sites called translocons (Johnson and van Waes,
1999). The translocon is formed by ER membrane proteins
that create an aqueous pore, and it also functions to translo-
cate secretory proteins across the ER membrane. Transloca-
tion is the default pathway, and translocation of the nascent
chain proceeds to completion unless a transmembrane
(TM)* sequence in the nascent chain causes translocon
function to convert to integration (Liao et al., 1997).
An important and intriguing mechanistic question is how
TM segment insertion and the proper localization of cyto-
plasmic and lumenal domains can be achieved during
cotranslational membrane protein integration without com-
promising the permeability barrier across the ER membrane.
This barrier must be maintained because calcium ions are
stored in the ER and the unregulated release of these potent
second messengers would have severe metabolic conse-
quences for the cell. During cotranslational translocation,
the aqueous translocon pore is sealed at its cytoplasmic end
by the tight binding of the ribosome to the translocon
(Crowley et al., 1994). However, this mechanism is clearly
not sufficient for membrane protein integration because the
ribosome–translocon seal must be broken to allow newly
synthesized cytoplasmic domains of the nascent membrane
protein to move into the cytoplasm during the cotransla-
tional integration process.
Liao et al. (1997) examined the integration of a signal-
cleaved, single-spanning membrane protein, and found
that the ribosome–translocon structure is tightly regulated
during integration to ensure that the ER membrane remains
sealed to ion flow. They discovered that after the TM se-
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quence had been synthesized and was still inside the ribo-
some, the translocon pore was sealed from the lumenal side,
and that shortly thereafter the cytoplasmic ribosome–trans-
locon seal was opened. Presumably, this sequence of events
constitutes a safety mechanism by ensuring that the lumenal
end of the pore is closed before the cytoplasmic end is
opened. These experiments also demonstrated that pore clo-
sure was mediated by a very long signal transduction path-
way that extends from far inside the ribosome to the other
side of the ER membrane (Liao et al., 1997).
By what mechanism is the lumenal end of the translocon
pore closed or gated during membrane protein integration?
One possibility is that a conformational change in the trans-
locon narrows the pore and thereby prevents ion flow (Fig. 1
a). Because the translocon has been shown to undergo struc-
tural changes that greatly alter pore diameter (Hamman et
al., 1997, 1998), this is a likely possibility. Alternatively, the
translocon may disassemble so that the pore disappears (Fig.
1 b). We consider this an unlikely scenario because the
translocon pore remains intact even when no ribosome is
bound to the translocon (Hamman et al., 1998). A third
possibility is that a soluble lumenal protein effects, directly
or indirectly, closure of the pore (Fig. 1 c). Consistent with
such a scenario, BiP, a lumenal Hsp70, is responsible for
closing the translocon pore before ribosome binding and for
a short time after the ribosome is targeted to the translocon
(Crowley et al., 1994; Hamman et al., 1998). However, a
translocon at rest and a translocon engaged in integration
differ structurally because the latter is bound to a ribosome
and also has a nascent chain extending through the translo-
con (Liao et al., 1997). If some lumenal protein closes the
pore during integration as depicted in Fig. 1c, the presence
of the nascent chain makes the closure mechanism substan-
tially more complicated than that of BiP closing a ribosome-
free translocon pore that lacks a nascent chain. An even
greater complication is the fact that not all pores occupied
by a nascent chain will be closed: those pores translocating
secretory proteins will not be closed (Crowley et al., 1994),
and only some pores occupied by a nascent membrane pro-
tein will be closed at any given time (Liao et al., 1997).
Thus, irrespective of the mechanism of pore closure, a so-
phisticated regulatory mechanism must have evolved for
identifying which pores containing nascent chains need to
be closed. In this study, a fluorescence quenching approach
was used to examine these important and fundamental issues
and to distinguish between the above three possibilities.
 
Results
 
Experimental approach
 
Fluorescent integration intermediates.  
 
To directly monitor
the exposure of a nascent membrane protein to each side of
the ER membrane during integration, a fluorescent probe is
incorporated into the nascent chain of an integration inter-
mediate. A homogeneous population of integration interme-
diates is generated by in vitro translation of mRNAs that are
truncated in the coding region (Liao et al., 1997). The ribo-
some halts when it reaches the end of such a truncated
mRNA, but the nascent chain and peptidyl-tRNA remain
bound to the ribosome because there is no stop codon.
 
Therefore, the length of the nascent chain in an intermedi-
ate is dictated by the length of the truncated mRNA, and
different stages in the process of integration can be examined
simply by increasing the length of the truncated mRNA in a
translation containing SRP and ER microsomes.
When in vitro translation is performed in the presence of
a Lys-tRNA analogue with a fluorescent probe covalently at-
tached to the lysine side chain, the fluorescent amino acid
will be incorporated into the nascent chain in response to a
lysine codon in the mRNA. Thus, a fluorescent probe can be
incorporated into an integration intermediate at a defined
location to serve as a probe of the local nascent chain envi-
ronment during integration. For the experiments described
here, we have employed N
 
 
 
-(6-[7-nitrobenz-2-oxa-1,3-
diazo-4-yl]aminohexanoyl)-Lys-tRNA (
 
 
 
NBD-Lys-tRNA)
(Crowley et al., 1993).
A chimeric single-spanning membrane protein designated
111p that has been well characterized previously (Liao et al.,
1997) was used in this study (Fig. 2 a). The 111p coding se-
quence contains only a single lysine codon that positions a flu-
orescent probe in the center of the nascent chain TM sequence
in each integration intermediate. At the lengths of nascent
chain analyzed in this study, the TM sequence, and therefore
the fluorescent probe, are located in the ribosomal nascent
chain tunnel in each integration intermediate (Fig. 2 b).
 
Fluorescence quenching.  
 
Accessibility of the fluorescent
probe in the nascent chain to either the cytoplasm or the
lumen can be determined using hydrophilic collisional
quenchers of NBD such as iodide ions. When a collisional
quencher contacts an excited fluorescent dye, the excited
state energy of the fluorophore is lost without the emission
of a photon. The resulting decrease in fluorescence intensity
is directly proportional to the number of collisions, and
hence to the quencher concentration, as expressed in the
Stern-Volmer equation: (F
 
o
 
/F) – 1 
 
 
 
 K
 
sv
 
[Q], where F
 
o
 
 is the
emission intensity in the absence of quencher, F is the emis-
sion intensity at quencher concentration [Q], and K
 
sv
 
 is the
Stern-Volmer constant. Therefore, the extent of quenching
is given by the K
 
sv
 
, where higher K
 
sv
 
 values indicate increased
quenching (Crowley et al., 1993, 1994).
When iodide ions are added to microsomes containing
fully assembled integration intermediates, any nascent chain
Figure 1. Three possible mechanisms for sealing the lumenal side 
of the aqueous translocon pore during protein integration. (a) A 
conformational change in the translocon prevents ion flow through 
the pore from the lumenal end. (b) Disassembly of the translocon 
machinery maintains the permeability barrier of the membrane by 
eliminating the pore. (c) A soluble lumenal protein mediates, either 
directly or indirectly, the closure of the lumenal side of the aqueous 
translocon pore. 
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probes that are accessible to the aqueous cytosol will be colli-
sionally quenched. To assess the accessibility of a nascent
chain probe to the lumenal side of the ER membrane, iodide
ions are introduced into the microsome interior using a
pore-forming toxin to create large holes in the ER mem-
brane (Crowley et al., 1994). Perfringolysin O (PFO) is a
member of a family of cytolytic bacterial toxins that oligo-
merize to form holes 
 
 
 
300 Å in diameter in cholesterol-
containing membranes (Heuck et al., 2001). Thus, after
PFO addition, quenchers can move freely into the lumenal
compartment of the microsomes (Crowley et al., 1994;
Hamman et al., 1997, 1998; Liao et al., 1997). Therefore,
nascent chain probes exposed to either the cytoplasmic or
the lumenal side of the ER are quenched by iodide ions in
the presence of PFO.
Collisional quenching experiments can also be used to es-
timate the size of an aqueous pore that links two aqueous
compartments. When a fluorescent probe is constrained to
one compartment and quenchers are added to the other
compartment, collisional quenching will be observed only if
the hydrophilic quenchers are sufficiently small to pass
through the aqueous pore connecting the two compart-
ments. This was the approach used to determine that a ribo-
some-free translocon has a diameter of 9–15 Å (iodide ions,
but not ADP molecules, pass through this pore) (Hamman
et al., 1998). In contrast, a translocon engaged in transloca-
tion has a diameter of 40–60 Å (NAD
 
 
 
 molecules, but not a
Fab fragment, pass through such a pore even though it also
contains a nascent chain) (Hamman et al., 1997).
 
Microsomes with different lumenal contents.  
 
To distin-
guish between the various mechanisms of sealing the translo-
con during integration (Fig. 1), microsomes were prepared
that contained a full complement of soluble lumenal proteins,
no soluble lumenal proteins, or a single purified lumenal pro-
tein. When salt-washed ER microsomes (KRMs) are treated
with high pH buffer followed by dilution, their soluble lume-
nal contents are released (Bulleid and Freedman, 1988; Nic-
chitta and Blobel, 1993; Hamman et al., 1998). These lu-
men-extracted microsomes (XRMs) can be resealed without
any loss in translocon function. Thus, integration intermedi-
ates prepared with XRMs can be used to determine whether a
soluble lumenal protein is responsible for sealing the lumenal
side of the translocon during integration (Fig. 1 c). This goal
is addressed most directly by focusing on an integration inter-
mediate that is normally sealed at both ends of the translocon
pore so that the NBD-labeled nascent chain is inaccessible to
quencher added from either side of the ER membrane (Liao
et al., 1997). Such intermediates prepared with KRMs should
exhibit no quenching by either cytoplasmic or lumenal iodide
ions, whereas the same intermediates prepared with XRMs
should be quenched if a soluble lumenal protein is involved in
sealing the pore (Fig. 1 c). On the other hand, this XRM in-
termediate would remain inaccessible to quenchers if the lu-
menal end of the pore is closed by a mechanism independent
of soluble lumenal proteins, such as a conformational change
in the translocon pore (Fig. 1, a and b).
Empty XRMs can also be refilled with a purified pro-
tein(s) to form reconstituted microsomes (RRMs). To pre-
pare RRMs, XRMs are first incubated with the purified pro-
tein in high pH buffer. When the pH is neutralized, the
opened microsomes reseal and encapsulate the purified pro-
tein to yield sealed RRMs that contain the desired protein in
their lumenal compartments. If a soluble lumenal protein is
implicated in sealing the lumenal side of the translocon dur-
ing integration, the identity of that protein can be deter-
mined by identifying which protein(s) encapsulated in
RRMs are able to close the lumenal end of the pore in inte-
gration intermediates (Hamman et al., 1998).
 
A soluble protein is responsible for sealing the lumenal 
side of the translocon during integration
 
Liao et al. (1997) identified a stage in the integration process
where the nascent chain was not accessible from either the
cytoplasmic or the lumenal side of the ER membrane. When
Figure 2. 111p protein and integration inter-
mediates. (a) The chimeric 111p single-spanning 
membrane protein was constructed using the TM 
sequence from vesicular stomatitus G protein 
(residues 65–84, dark gray) and lysine-free 
stretches of preprolactin and Bcl-2 (Liao et al., 
1997). 111p contains only a single lysine codon 
at position 75 in the middle of the TM sequence 
(white circle). Note that the TM segment will still 
be nonpolar and uncharged when  NBD-Lys is 
incorporated at this location. The signal sequence 
(SS) is indicated in gray (residues 1–22), and the 
triangle indicates the approximate position of the 
truncations used in this study (residues 86, 91, and 
93). (b) Accessibility of the fluorescent probe from 
either the cytoplasmic or lumenal sides of intact ER 
microsomes is indicated for each intermediate 
used in this study (Liao et al., 1997). The ribosome 
is shown bound to the translocon (black) at the 
ER membrane (light gray) in each case. The TM 
sequence is represented by a dark gray rectangle 
and the fluorescent probe by a white circle. 
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fluorescent integration intermediates containing an NBD-
labeled, 91-residue 111p nascent chain (NBD-111p-91) and
intact ER microsomes (KRM) were exposed to iodide ions,
little collisional quenching of NBD fluorescence was ob-
served (K
 
sv
 
 
 
 
 
 0.5 M
 
 
 
1
 
) (Fig. 3 a; Table I). Because the K
 
sv
 
 is
 
 
 
2.5 M
 
 
 
1
 
 when the same translation intermediate is not
bound to the ER membrane (Liao et al., 1997), it is clear
that the formation of the integration intermediate prevents
iodide ion access to most nascent chain probes. As we have
shown previously, residual quenching results from a combi-
nation of effects, each of which exposes a small number of
NBD-labeled nascent chains to the cytoplasm. Some prop-
erly targeted integration intermediates dissociate from the
translocon during the long spectroscopic measurements
(Crowley et al., 1994), some nontargeted nascent chains ad-
sorb to the outer microsomal membrane (this effect is worse
with membrane proteins) (Hamman et al., 1997), and some
ribosomal complexes are purified with the microsomes as
part of a polysome (Hamman et al., 1997). Limited protease
and ribonuclease treatment of the microsomes can eliminate
nearly all of the NBD dyes exposed to (quenched by) cyto-
plasmic iodide ions and hence reduce the initial K
 
sv
 
 values to
near 0 (Hamman et al., 1997). However, we have chosen
here to avoid any risk of damaging the samples and focus in-
stead on the difference, if any, in quenching between cyto-
plasmic and lumenal iodide ions (see below).
Because hydrophilic iodide ions do not pass through a
phospholipid bilayer (Cranney et al., 1983; Crowley et al.,
1994), nascent chain exposure to the lumenal side of the
membrane can be evaluated upon introduction of iodide
ions into the interior of the microsomes using PFO. When
PFO was added to the above NBD-111p-91 integration in-
termediate sample, no increase in iodide ion quenching of
NBD emission was observed (Fig. 3 a; Table I). The identi-
cal K
 
sv
 
 values before and after quenchers were introduced
into the lumenal compartment show that the 111p-91 na-
scent chain and its fluorophore are not exposed to the lume-
nal side of the membrane. Thus, the lumenal end of the
translocon pore is closed at this stage of the integration pro-
cess.
The inaccessibility of the nascent chain from the cytoplas-
mic side is explained by the tight ribosome-translocon seal.
However, in order to determine the mechanism of lumenal
sealing at this stage of membrane protein integration, colli-
sional quenching experiments were performed on integra-
tion intermediates prepared with XRM microsomes that
lacked soluble lumenal proteins. Lumenal extraction re-
moves the BiP that normally seals ribosome-free translocons
(Hamman et al., 1998), and this allows cytoplasmic iodide
ions to diffuse into the lumenal interiors of the XRMs, even
in the absence of PFO, through the pores of those translo-
cons that are not bound to ribosomes (
 
 
 
50%) (Hamman et
al., 1997). Such iodide ions would be expected to quench
the probe in the NBD-111p-86 intermediate, as its pore is
normally open to the ER lumen (Fig. 2 b). When NBD-
111p-91 integration intermediates containing XRMs were
treated with cytoplasmic iodide ion quenchers, maximal
Figure 3. Iodide ion quenching of 
NBD-labeled 111p-91 integration 
intermediates prepared with various ER 
microsomes. Samples containing NBD-
111p-91 integration intermediates pre-
pared with (a) KRMs, (b) XRMs, (c) XRMs   
 Sec61 , or (d) RRMs (XRMs reconsti-
tuted with rBiP) were divided into four 
equal aliquots. Each sample then received 
the same total concentration of KCl and 
KI, but different amounts of KI as shown. 
Fo is the net fluorescence intensity in the 
absence of quencher, whereas F is the net 
fluorescence intensity at a given iodide 
ion concentration. Measurements were 
made in the absence ( ) or the presence 
( ) of pore-forming PFO toxin to intro-
duce iodide ions into the lumen of the 
microsomes. The linear least-squares 
best-fit lines for data averaged from 
several independent experiments are 
shown. The results are also reported 
in Tables I and II.
 
Table I. 
 
Iodide ion quenching of NBD-labeled integration 
intermediates in intact and lumen-extracted ER microsomes
Intermediate components Observed K
 
sv
 
 (M
 
 
 
1
 
)
 
 
 
PFO
 
 
 
PFO
 
111p-86 
 
• 
 
KRM
 
a
 
0.4 1.8
111p-86
 
 
 
• 
 
XRM
 
1.7 1.8
 
111p-86
 
 
 
• 
 
XRM 
 
   
 
Sec61
 
 
 
b
 
0.9 1.7
 
111p-91
 
 
 
• 
 
KRM
 
a
 
0.5 0.5
 
111p-91
 
 
 
• 
 
XRM
 
2.2 2.5
 
111p-91
 
 
 
• 
 
XRM 
 
   
 
Sec61
 
 
 
b
 
1.3 2.8
 
111p-93
 
 
 
• 
 
KRM
 
a
 
3.6 3.7
 
111p-93 
 
• 
 
XRM 3.0 2.8
The K
 
sv 
 
values shown are the average of 3–5 independent experiments
except where indicated. The standard deviations for the K
 
sv 
 
values were:
 
 
 
0.2 M
 
 
 
1
 
 for KRM measurements; 
 
 
 
0.1–0.3 M
 
 
 
1
 
 for XRM – PFO
measurements; and 
 
 
 
0.1–0.4 M
 
 
 
1
 
 for XRM 
 
 
 
 PFO measurements. Samples
were prepared as described in Materials and methods.
 
a
 
Taken from Liao et al. (1997).
 
b
 
The K
 
sv 
 
values are the average of two independent experiments. 
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quenching was observed both in the presence and absence of
PFO (Fig. 3 b; Table I). Because minimal quenching of
NBD-111p-91 by iodide ions was observed in intermediates
containing intact KRM microsomes both in the presence
and absence of PFO (Fig. 3 a), lumenal extraction must
compromise the seal in XRM-containing intermediates.
To determine whether the iodide ions were indeed enter-
ing the lumen via unoccupied translocon pores, we took ad-
vantage of previous work that had revealed that the binding
of Sec61
 
 
 
-specific antibodies to ribosome-free translocons
occludes the translocon so that iodide ion flow through the
pore is severely inhibited (Hamman et al., 1998). Thus, ad-
dition of these affinity-purified antibodies to a sample before
iodide ion addition would reduce the extent of quenching if
iodide ions were accessing the nascent chains from the lume-
nal side of the membrane after passage through ribosome-
free translocons. As shown by Fig. 3 c and the data in Table
I, the addition of Sec61
 
 
 
-specific antibodies to samples dra-
matically reduced the observed K
 
sv
 
 values for both the NBD-
111p-86 XRM and NBD-111p-91XRM intermediates in
the absence of PFO. When PFO was added and iodide ions
were allowed full access to the lumen, quenching of both in-
termediates reached the maximal level (Fig. 3 c; Table I).
Therefore, iodide ions had to first pass through a ribosome-
free translocon before being able to collisionally quench the
nascent chain probes from the lumenal side.
The lumenal end of the pore in the 111p-91 integration
intermediate is normally closed to the ER lumen (Fig. 2 b;
Table I). Two of the possible mechanisms for pore closure,
gating of the translocon pore by a conformational change or
disassembly of the translocon (Fig. 1, a and b), would be in-
dependent of the soluble lumenal protein content of the mi-
crosomes. Therefore, if a conformational change in the
translocon or its disassembly were responsible for sealing the
lumenal side of the translocon during integration, we would
have expected no difference in the iodide ion quenching for
NBD-111p-91 between intact and lumen-extracted micro-
somes. However, when microsomes are devoid of soluble
lumenal protein contents, maximal quenching of the fluo-
rescent probe in NBD-111p-91 XRM intermediates was ob-
served from the lumenal side of the translocon (Fig. 3, b and
c; Table I). These results strongly indicate that a soluble lu-
menal protein is responsible for maintaining the permeabil-
ity barrier at this stage of integration (Fig. 1 c).
 
BiP is responsible for maintaining the permeability 
barrier during cotranslational integration
 
Because a soluble lumenal protein appears to be required to
seal the lumenal side of the translocon, the protein responsi-
ble for closing the pore can be identified by reconstituting
purified lumenal proteins back into lumen-extracted mi-
crosomes and determining which single protein or combina-
tion of proteins restores the seal at the lumenal end of the
pore of the NBD-111p-91 intermediate. A good candidate
protein is the lumenal Hsp70, BiP, because Hamman et al.
(1998) showed that BiP is required to seal the pore in a ribo-
some-free translocon. Although the translocon structure is
likely to be substantially different during cotranslational in-
tegration because of the bound ribosome (Hamman et al.,
1997) and the nascent chain threading through the translo-
con, it was reasonable to first test whether BiP was involved
in maintaining the permeability barrier of the ER membrane
during integration.
Thus, lumen-extracted microsomes (Bulleid and Freed-
man, 1988; Nicchitta and Blobel, 1993; Hamman et al.,
1998) were reconstituted with purified recombinant ham-
ster BiP protein (rBiP) (Gaut and Hendershot, 1993) to
yield RRMs. Integration intermediates prepared with these
rBiP-containing RRMs were then analyzed to determine the
exposure of the fluorescent nascent chain to the cytoplasm
and the ER lumen. As expected, the purified rBiP protein
mediated the closure of ribosome-free translocon pores, as
evidenced by the inability of cytoplasmic iodide ions to en-
ter the lumenal compartment of the RRM microsomes and
quench the NBD-111p-86 nascent chain probe in the ab-
sence of PFO (Table II). This rBiP-dependent protection of
the nascent chain from access to cytoplasmic iodide ions was
effected from the lumenal side of the ER membrane, and
was not a nonspecific effect because the nascent chain in the
NBD-111p-93 RRM intermediate was maximally quenched
by cytoplasmic iodide ions in the absence of PFO (Table II).
Because the same RRMs were used to prepare the NBD-
111p-86, NBD-111p-91, and NBD-111p-93 intermediates,
the NBD-111p-93 results serve as an important internal
control for this spectroscopic approach, and also show, as ex-
pected (Liao et al., 1997), that the NBD-111p-93 nascent
chain is exposed to the cytosol during integration (Fig. 2 b).
When iodide ions were introduced into the lumenal
compartment of RRMs using PFO, NBD-111p-86 was
quenched as in the KRM-containing intermediates, thereby
showing that the translocon is open on the lumenal side at
this stage of integration (Table II). However, with NBD-
111p-91 RRM intermediates, no additional quenching was
observed after PFO was added (Fig. 3 d; Table II). There-
fore, the seal at the lumenal end of the translocon in this in-
tegration intermediate is restored upon reconstitution of the
microsomes with purified rBiP protein. The sealing by rBiP
is specific to the 111p-91 nascent chain intermediate, and
does not result from indiscriminate sealing of translocon
pores because the 111p-86 intermediate is not sealed under
the same conditions. Therefore, the 111p-86 and 111p-91
data constitute another important internal control by dem-
onstrating that translocon closure is not due to a nonspecific
 
Table II. 
 
Iodide ion quenching of NBD-labeled integration 
intermediates in ER microsomes reconstituted with rBIP
Intermediate components Observed K
 
sv
 
 (M
 
 
 
1
 
)
 
 
 
PFO
 
 
 
PFO
 
111p-86 
 
• 
 
RRM 0.4 2.0
111p-86
 
 
 
• 
 
RRM 
 
 
 
 
 
 
 
BiP
 
1.8 2.0
 
111p-86
 
 
 
• 
 
RRM 
 
 
 
 AMPPNP
 
2.0 2.0
 
111p-91
 
 
 
• 
 
RRM
 
0.9 0.8
 
111p-91
 
 
 
• 
 
RRM 
 
 
 
 
 
 
 
BiP
 
2.4 2.4
 
111p-91
 
 
 
• 
 
RRM 
 
 
 
 AMPPNP
 
2.5 2.6
 
111p-93 
 
• 
 
RRM 2.6 3.1
The K
 
sv 
 
values shown are the average of 3–4 independent experiments. The
standard deviations were 
 
 
 
0.2 M
 
 
 
1
 
 for RRM – PFO measurements, and
between 0.2 and 0.4 M
 
 
 
1 
 
for all other measurements. Samples were
prepared as described in Materials and methods. 
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effect such as BiP binding to partially unfolded translocon
proteins. These data also demonstrate that the ribosome–
translocon seal in these integration intermediates is not dis-
rupted by the extraction or reconstitution procedures.
Thus, rBiP reconstituted into RRMs is able to seal the lu-
menal side of the translocon pore during cotranslational in-
tegration. The rBiP-reconstituted microsomes behave ex-
actly as the KRMs in the iodide ion collisional quenching
experiments, demonstrating that BiP is the only soluble lu-
menal protein required to restore the seal (compare Table I,
KRM, and Table II, RRM).
Several control experiments were performed to demon-
strate that the closure of the lumenal side of the translocon
pore during integration is due specifically to the rBiP pro-
tein. When affinity-purified antibodies against the BiP pro-
tein are added to an rBiP sample before reconstitution into
the microsomes, maximum quenching by iodide ions is ob-
served in the absence and presence of PFO for the NBD-
111p-86 and NBD-111p-91 intermediates (Table II). The
extents of quenching are equivalent to those obtained with
lumen-extracted microsomes that contain no soluble lume-
nal proteins (compare Table I, XRM, and Table II, RRM 
 
 
 
 
BiP). Thus, the binding of the BiP-specific IgG molecules
to the rBiP molecules prevented the latter from sealing the
ER translocons. These results strongly indicate that the BiP
protein is solely responsible for gating the translocons ac-
tively engaged in integration.
The BiP protein is an Hsp70 family member with a highly
conserved NH
 
2
 
-terminal ATPase domain (Bukau and Hor-
wich, 1998; Gething, 1999). To determine whether closure
of the translocon pore during integration requires ATP hy-
drolysis, AMPPNP, a nonhydrolyzable ATP analogue, was
reconstituted into RRMs in place of ATP. When rBiP pro-
tein was preincubated with an excess of AMPPNP and then
reconstituted into RRMs, the rBiP protein was no longer able
to close the lumenal side of the translocon in the 111p-91 in-
tegration intermediate (Table II). In agreement with previous
results (Hamman et al., 1998), rBiP treated with AMPPNP
was also unable to seal the ribosome-free translocon pores
(Table II, 111p-86, and 111p-91, -PFO). This ATP depen-
dence of translocon closure is consistent with BiP involve-
ment, and also reveals the mechanistic involvement of ATP
hydrolysis in the BiP-mediated closure of the lumenal end of
the translocon pore during cotranslational integration.
 
The translocon pore contracts during integration
 
We previously showed that the diameter of the aqueous
translocon pore was 40–60 Å during translocation (Ham-
man et al., 1997), but was dramatically reduced to 9–15 Å
after translation terminated and the ribosome dissociated
from the translocon (Hamman et al., 1998). Is the size of
the pore altered during integration? As noted earlier, a direct
method for estimating the minimum diameter of an aque-
ous pore is to determine whether a hydrophilic collisional
quencher of known dimensions is able to diffuse passively
through the pore. In the following experiments, the fluores-
cent probe was located inside the aqueous nascent chain tun-
nel of a ribosome that forms a tight seal with the translocon,
whereas quenchers were introduced into the aqueous lume-
nal compartment of the ER microsomes. Quenching was
 
then observed only if the quencher moieties were small
enough to pass through the pore in the translocon, the only
aqueous pathway into the ribosomal tunnel.
Large quenchers such as nicotinamide adenine dinucle-
otide (NAD
 
 
 
), with anhydrous dimensions of 
 
 
 
11 
 
 
 
 12 
 
 
 
20 Å (Bell and Eisenberg, 1996; Li et al., 1996) and a single
net negative charge, are able to traverse the translocon pore
of a translocation intermediate containing a preprolactin
(pPL) nascent chain (Table III; Hamman et al., 1997).
Once introduced into the ER lumen (Table III, 
 
 
 
PFO), the
NAD
 
 
 
 is able to pass through the translocon and far into
the nascent chain tunnel to quench the probes in the pPL
nascent chain (K
 
sv
 
 
 
 
 
 1.8 M
 
 
 
1
 
). Thus, during secretory pro-
tein translocation at the ER membrane, the translocon pore
is large enough to accommodate and freely pass both the na-
scent chain and large hydrated NAD
 
 
 
 molecules (Hamman
et al., 1997). However, during membrane protein integra-
tion, different quenching results are obtained that indicate a
structural change at the translocon.
In the absence of BiP, iodide ions (anhydrous diameter
 
 
 
4 Å) are able to move freely through the translocon pore of
a NBD-111p-91 XRM integration intermediate despite the
presence of the 111p-91 nascent chain in the translocon pore
and ribosomal tunnel (Fig. 3 b; Table I). However, when the
larger NAD
 
 
 
 molecules were used as quenchers with the same
integration intermediates, no NAD
 
 
 
 was able to move from
the lumenal compartment into the nascent chain tunnel. This
was shown by the absence of any increase in quenching when
PFO was added to introduce NAD
 
 
 
 into the lumenal com-
partments of the microsomes (Table III). The inability of
NAD
 
 
 
 to quench the 111p-91 probe from the lumenal side
of the ER membrane is not due to the inability of NAD
 
 
 
 to
move into the ribosomal tunnel, because NAD
 
 
 
 molecules
are able to efficiently quench the nascent chain probes inside
the ribosome both in the pPL translocation intermediate and
also in the NBD-111p-93 XRM intermediate (Table III). In
the latter case, NAD
 
 
 
 is able to enter and move into the na-
scent chain tunnel from the cytosol rather than through the
translocon pore because the ribosome–translocon seal has
been broken (Fig. 2 b). This result also reveals that when the
ribosome–translocon seal is broken during integration to al-
low the cytoplasmic domain of the nascent chain to enter the
cytoplasm, the opening between the ribosome and the mem-
brane is sufficiently large to freely pass NAD
 
 
 
 molecules.
Thus, NAD
 
 
 
 is unable to quench the probe in the 111p-
91 XRM intermediate because the quencher cannot pass
 
Table III. 
 
NAD
 
  
 
quenching of NBD-labeled translocation and 
integration intermediates in lumen-extracted ER microsomes
Intermediate components Observed K
 
sv
 
 (M
 
 
 
1
 
)
 
 
 
PFO
 
 
 
PFO
 
pPL-sK-78 
 
• 
 
XRM 0.4 1.8
111p-86 
 
• 
 
XRM 0.0 0.1
111p-91 
 
• 
 
XRM 0.5 0.5
111p-93 
 
• 
 
XRM 1.8 1.7
The K
 
sv 
 
values shown are the average of 2–3 independent experiments. The
standard deviations were between 0.1 and 0.4 M
 
 
 
1
 
 for all measurements.
Samples were prepared as described in Materials and methods. The
modified pPL construct, pPL-sK-78, is described in Crowley et al. (1994). 
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through the translocon pore into the ribosome. Because
NAD
 
 
 
 can move through the translocon pore when it is
opened to the lumen during translocation (Hamman et al.,
1997; Table III), it is clear that the translocon contracts dur-
ing integration. However, the pore is not completely closed
in the absence of BiP, as shown by the quenching of the
probe in the NBD-111p-91 XRM intermediate by iodide
ions (Table I). Because the pore contracts in the 111p-91
XRM intermediates even though BiP is absent, it is possible
that this structural change is part of the signal transduction
mechanism (Liao et al., 1997) by which changes inside the
ribosome and at the ribosome–translocon interface are trans-
mitted to the other side of the membrane to signal the need
to initiate BiP-mediated closure of the pore. In any event,
these results demonstrate once again the dynamic nature of
translocon structure (Johnson and van Waes, 1999).
 
Discussion
 
A critical factor in mammalian cell viability is its ability to
maintain and regulate the permeability barrier of the ER
membrane. In particular, Ca
 
2
 
 
 
 ion flow must be controlled
during cotranslational protein translocation and integration.
We have shown in this study that BiP is required to seal the
lumenal end of the aqueous translocon pore during the
cotranslational integration of a nascent membrane protein,
and hence to maintain the permeability barrier of the ER
membrane during this complex process. BiP alone is suffi-
cient to effect the closure of the translocon pore in the ab-
sence of all other soluble lumenal proteins, and ATP hydro-
lysis is required to seal the pore.
This discovery identifies a new functional role for the BiP
protein. BiP is best known for its activity as a resident chap-
erone of the ER lumen, where BiP assists protein folding
and assembly by ATP-dependent cycles of binding to hydro-
phobic stretches in polypeptides (Gething and Sambrook,
1992; Simons et al., 1995; Gething, 1999). However, BiP is
clearly a multifunctional protein because it is also required
for posttranslational translocation in yeast (Nguyen et al.,
1991; Sanders et al., 1992; Brodsky and Schekman, 1993;
Panzner et al., 1995; Brodsky, 1996; Matlack et al., 1999;
Pilon and Schekman, 1999). Furthermore, although BiP
was not required to detect cotranslational translocation in
a purified, reconstituted system (Görlich and Rapoport,
1993), other studies have shown that BiP is required for
cotranslational translocation in yeast (Brodsky et al., 1995;
Young et al., 2001) and possibly in mammals (Nicchitta and
Blobel, 1993). BiP also plays a role in retrotranslocation,
and is upregulated as a result of the unfolded protein re-
sponse (Chapman et al., 1998; Brodsky and McCracken,
1999; Gething, 1999; Plemper and Wolf, 1999; Römisch,
1999; Johnson and Haigh, 2000; Patil and Walter, 2001).
In addition, BiP seals the aqueous pore of a ribosome-free
ER translocon in mammalian cells (Hamman et al., 1998).
This last function of BiP, closing ribosome-free translocon
pores, is structurally and mechanistically distinct from its
role in closing translocon pores that are actively engaged in
integrating nascent membrane proteins into the membrane
bilayer. Ribosome-free translocons have aqueous pores with a
small diameter (9–15 Å), and there is no nascent chain in the
pore when BiP effects pore closure (Hamman et al., 1998).
In contrast, we have shown that the nascent chain extends
through the translocon and into the ER lumen when the
pore is closed during integration (Liao et al., 1997). There-
fore, the presence of the nascent chain in the translocon and
of the ribosome at the translocon creates a structural problem
in terms of how to seal the pore, and also in terms of when to
seal the pore. For example, it is easy to imagine that an
empty translocon pore would automatically and immediately
be recognized by BiP as a substrate for closure. Furthermore,
BiP-mediated closure of such a pore could be elicited either
by BiP binding directly to the lumenal end of the pore and
plugging it (compare Fig. 1 c) and/or by binding elsewhere
to a translocon protein and thereby initiating a conforma-
tional change that closes the pore (compare Fig. 1 a).
However, the mechanism by which BiP seals a translocon
pore during integration is distinguished by the presence of
the nascent chain. Despite the complication caused by the
nascent chain, BiP could still mediate closure either directly
by plugging the pore with the nascent chain in it (Fig. 1 c)
and/or indirectly by initiating a conformational change that
closes down upon the nascent chain (Fig. 1 a). In fact, pore
closure during integration appears to involve a combination
of the mechanisms depicted in Fig. 1, a and c. The detection
of the TM sequence in the nascent chain inside the ribo-
some (Liao et al., 1997) causes the translocon pore to con-
tract from its large NAD
 
 
 
-permeable diameter to a diameter
that is too small to pass NAD
 
 
 
 (Table III). But this confor-
mational change does not completely close the pore, as io-
dide ions can still move through the pore (Table I). BiP and
ATP hydrolysis are then required to seal the pore (Table II).
However, it remains to be seen exactly how the pore is
closed with the nascent chain present and exactly where the
nascent chain is located in the sealed translocon.
The timing of BiP-mediated pore closure is also more
complicated when a nascent chain occupies a translocon
pore. Only some of the translocons bound to ribosomes are
synthesizing membrane proteins, and of those, only a frac-
tion require sealing by BiP at any given time to allow
nascent chain exposure to the cytoplasm. Therefore, recog-
nition of a translocon engaged in integration and distin-
guishing it from one engaged in translocation is much more
difficult for BiP than is recognition of a nascent chain-free
translocon. A sophisticated mechanism must recognize
which of the translocons engaged in integration require pore
closure to allow a cytoplasmic domain of a nascent mem-
brane protein to enter the cytosol. One possible mechanism
is the ribosome-mediated contraction of the translocon pore,
as suggested in the last section of the Results and discussed
further below.
Whatever mechanism triggers pore closure, it is conceiv-
able that BiP transiently and repeatedly binds to nascent
chain-containing translocons to identify those in need of
closure. However, it seems more likely that BiP remains
bound to a translocon throughout translation so that it can
either close or open the pore as necessary during the synthe-
sis and integration of a nascent membrane protein. A few
proteins have been identified that could serve to localize BiP
at the ER membrane. One mammalian ER membrane pro-
tein, MTJ1, has been shown to bind and activate BiP (Che- 
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valier et al., 2000). In yeast, the BiP homologue, Kar2p, is
bound to the ER membrane surface via Sec63p (Lyman and
Schekman, 1995; Corsi and Schekman, 1997; Misselwitz et
al., 1999). Because Young et al. (2001) found that Sec63p is
required for SRP-dependent translocation in vivo in yeast, it
seems likely that Sec63p is also involved in binding and lo-
calizing BiP at the translocon during cotranslational translo-
cation and integration. A mammalian homologue of Sec63p
was recently discovered and found to be associated with the
translocon (Skowronek et al., 1999; Meyer et al., 2000;
Tyedmers et al., 2000), but the mammalian Sec63p has not
yet been shown to bind BiP.
An intriguing mechanistic feature of the integration pro-
cess for a signal-cleaved membrane protein is that BiP-medi-
ated closure of the translocon pore occurs while the TM se-
quence is located far inside the ribosome (Liao et al., 1997).
Thus, there is not only a means to identify a TM sequence
in a nascent chain inside the ribosome, but also a mecha-
nism for transmitting this information through the ribo-
some and then across the ER membrane to elicit closure of
the pore. Interestingly, an elongated protein adjacent to the
nascent chain tunnel in the large ribosomal subunit of the
50S subunit of the bacterial ribosome may be the conduit
for such signal transduction through the ribosome (Nissen et
al., 2000), though the extent of structural homology be-
tween the prokaryotic and eukaryotic ribosomes has yet to
be established in this region. As for transmittance of a signal
across the ER membrane to the lumenal side of the translo-
con, several transmembrane ER proteins found at the trans-
locon could interact with the pertinent ribosomal compo-
nent and carry out this function. In particular, both Sec61
 
 
 
and Sec63p are attractive candidates if, as is thought, they
bind to the ribosome and/or BiP, respectively, in mammals.
Although the other components of this very long, mem-
brane-spanning signal transduction pathway are not yet
known, we have shown here that BiP is essential for this
communication pathway. Thus, BiP is the first component
of this important signal transduction mechanism to be iden-
tified, a discovery that further increases the number of func-
tional roles attributed to BiP.
Images of translocation intermediates reconstructed from
cryo-EM data show a gap between the ribosome and Sec61
(Ménétret et al., 2000; Beckmann et al., 2001). Although
the resolution of the EM technique is not sufficient to detect
all of the polypeptide present (e.g., the nascent chain itself is
not visible), the apparent gap has led to speculation that the
ribosome does not form a seal or permeability barrier upon
binding to the translocon. Instead, Ca
 
2
 
 
 
 efflux from the ER
lumen is presumed to be prevented because the pore is too
small to permit ion transport, though no experimental mea-
surements of pore size in a membrane with an intact translo-
con were reported (Ménétret et al., 2000; Beckmann et al.,
2001). Because the translocation intermediates (Ménétret et
al., 2000) and the purified Sec61 proteins (Beckmann et al.,
2001) were solubilized in detergent before analysis in these
EM studies, the putative translocation intermediates lack a
membrane and some of the translocon-associated proteins
(e.g., TRAM, oligosaccharyltransferase, and signal pepti-
dase). In contrast to the EM studies, the fluorescence experi-
ments were done with intact membranes and complete
translocation intermediates, and these studies revealed an
ion-impermeable ribosome-translocon junction and a large
(40–60 Å in diameter) translocon pore (Crowley et al.,
1994; Hamman et al., 1997).
Thus, the simplest explanation for the apparent contradic-
tion between the EM and fluorescence experiments is that
the tight ribosome–translocon junction and the large pore of
the translocation intermediates cannot be maintained or
formed in the absence of some translocon components and/
or in the absence of the membrane. This would explain why
no significant difference was observed between the ribosome-
Sec61 images obtained in samples containing translation in-
termediates with nascent chains and those containing non-
translating ribosomes (Beckmann et al., 2001). Consistent
with this possibility, the small (
 
 
 
20 Å) diameter of the trans-
locon in EM reconstructions is similar to that of a ribosome-
free translocon in an intact ER membrane determined by
fluorescence (Hamman et al., 1998). Hence, translocation
intermediates in the Ménétret et al. (2000) study may have
been unable to withstand detergent treatment, even in the
presence of the nascent chain, and the translocon reverted to
its ribosome-free conformation when the dissolution of the
membrane and the loss of translocon components caused the
ribosome to disengage and break the tight junction or seal
between the ribosome and the translocon. Similarly, a puri-
fied ribosome–nascent chain complex in the Beckmann et al.
(2001) study may not be able to bind to a detergent-purified
Sec61 complex in the same way as it would to a fully assem-
bled translocon in an intact membrane.
However, the ribosomes and translocons in the EM stud-
ies clearly do interact in a meaningful way because the ribo-
somal exit site is localized close to the Sec61 complex in all
of the EM images. In fact, the ribosome and the Sec61 com-
plex are aligned by four specific connections that orient
them, but leave a gap between them (Beckmann et al.,
2001). These interactions are both strong and membrane in-
dependent because they survive EM preparation procedures
(Beckmann et al., 1997, 2001; Ménétret et al., 2000). In-
deed, these same interactions may be responsible for keeping
the ribosome near the translocon when the ribosomal seal is
broken to allow nascent chain movement into the cytosol
during integration (Fig. 4 d). However, because no gap
larger than 9 Å (the diameter of a hydrated iodide ion) be-
tween the cytoplasm and the ribosomal nascent chain tunnel
is detected in the fluorescence experiments with intact mem-
branes and translocons, we conclude that the gap observed
in reconstructed EM images of translocation intermediates
does not accurately depict all of the ribosome interactions
with a complete translocon in an intact membrane.
Maintenance of the permeability barrier during cotransla-
tional integration of a signal-cleaved single-spanning mem-
brane protein at the ER membrane therefore includes, at a
minimum, the structural states of the ribosome–translocon
complex shown in Fig. 4. Prior to integration, the small
aqueous pore of the ribosome-free translocon (9–15 Å diam-
eter) is sealed on the lumenal side by BiP either directly (as
shown in Fig. 4 a) or indirectly (Hamman et al., 1998). After
SRP-dependent targeting to the ER membrane, a ribosome
synthesizing a nascent protein binds tightly to the cytoplas-
mic side of the translocon to seal the large (40–60 Å) ribo- 
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some-bound pore that is open at its lumenal end after the
nascent chain reaches a length of 
 
 
 
70 residues (Fig. 4 b)
(Crowley et al., 1994; Hamman et al., 1997). The appear-
ance of a complete TM sequence in the nascent chain inside
the ribosome elicits translocon pore contraction and the clo-
sure of the lumenal end of the pore while the cytoplasmic
end remains closed (Fig. 4 c) (Liao et al., 1997). We have in-
dicated in Fig. 4, c and d, that BiP blocks the pore directly,
but BiP-mediated lumenal closure may be accomplished in-
directly. The ribosome–translocon seal is then broken to al-
low a cytoplasmic domain of the nascent chain to enter the
cytosol, whereas the BiP-dependent lumenal seal remains
closed (Fig. 4 d). After translation of the nascent chain has
been completed, the new membrane protein is released from
the translocon and inserted into the ER bilayer (Do et al.,
1996). Therefore, BiP plays a critical role in maintaining the
permeability barrier of the ER membrane during cotransla-
tional membrane protein integration. It will now be interest-
ing to determine which domains and residues of BiP are in-
volved in this function, and whether they are the same as
those involved in its other functions.
 
Materials and methods
 
Plasmids, mRNA, and protein purification
 
Construction of plasmid pJL111 encoding the 111p protein was described
previously (Do et al., 1996). Plasmid pSPJL111 was created by transferring
the KpnI–BssHII (Klenow-blunted) DNA fragment of pJL111 into pGEM4Z
using the KpnI and HindIII (Klenow-blunted) sites (unpublished data). To
produce nascent chains of defined lengths, plasmids were cleaved with re-
striction endonucleases within the coding region and transcribed in vitro
using SP6 RNA polymerase as before (Liao et al., 1997). Transcription of
EcoRI-, SpeI-, and SalI-cut pSPJL111 yielded truncated mRNAs coding for
the first 86, 91, and 93 amino acids of the 111p protein.
Plasmid pQEwtBiP, a gift of Dr. Linda Hendershot (St. Jude’s Children’s
Research Hospital, Memphis, TN), directs the IPTG-inducible expression
of mature hamster BiP protein with an amino-terminal 6
 
 
 
-histidine tag.
Recombinant hamster BiP protein was overexpressed and purified from
 
Escherichia coli
 
 as described previously (Gaut and Hendershot, 1993).
 
Integration intermediates
 
Integration intermediates containing 111p nascent chains of different
lengths were prepared as before (Liao et al., 1997). Translations were per-
formed in vitro as described previously (Crowley et al., 1993, 1994) using
wheat germ extract, either 
 
 
 
NBD-Lys-tRNA
 
Lys
 
 or unmodified Lys-tRNA
 
Lys
 
(Crowley et al., 1993), canine SRP, and 
 
 
 
100 equivalents of canine KRMs,
XRMs, or RRMs prepared as described below. After translation, KOAc, pH
7.5, was added to a final concentration of 0.5 M to newly synthesized inte-
gration intermediates, and they were incubated on ice for 10 min. Integra-
tion intermediates were then purified by gel filtration chromatography us-
ing a Sepharose CL
 
 
 
2B column (0.7 cm i.d. 
 
 
 
 50 cm) equilibrated and run
in buffer A (50 mM Hepes, pH 7.5, 40 mM KOAc, pH 7.5, 5 mM MgCl
 
2
 
).
Prior to sample loading, a 2-ml preload of high-salt buffer A (50 mM
Hepes, pH 7.5, 0.5 M KOAc, pH 7.5, 5 mM MgCl
 
2
 
) was run into the col-
umn to allow microsome separation from salt-sensitive NBD-containing
adsorbed material before the intermediates moved into buffer A in the col-
umn. Where indicated, affinity-purified antibodies against Sec61
 
 
 
 were in-
cubated with XRM-containing intermediates for 20 min on ice following
their purification by gel filtration and before fluorescence measurements.
After fluorescence measurements, the samples were analyzed biochemi-
cally to assess the extent of 
 
 
 
NBD-Lys incorporation and membrane asso-
ciation of ribosome–nascent chain complexes (Crowley et al., 1993).
 
Extraction of soluble lumenal proteins
 
Extraction of soluble lumenal proteins was performed by high pH treat-
ment as described (Nicchitta and Blobel, 1993; Hamman et al., 1998). A
100-
 
 
 
l volume of buffer B (500 mM Hepes/500 mM CAPS titrated to pH
9.5) was added to 100 equivalents of canine rough microsomes in 100 
 
 
 
l
of buffer C (50 mM Hepes, pH 7.5, 1 mM DTT, 200 mM sucrose), and this
mixture was diluted to 1 ml with water. After a 20-min incubation on ice,
the XRMs were collected by sedimentation through a 0.5-M sucrose cush-
ion in buffer A and resealed by resuspension in 100 
 
 
 
l buffer C at 4
 
 
 
C.
 
Reconstitution
 
Reconstitution was performed essentially as described in Bulleid and
Freedman (1988), a procedure similar to that used in our lab previously
(Hamman et al., 1998). XRMs were prepared as described above, except
that the microsomes were collected by sedimentation through a high pH
cushion (0.5 M sucrose in 0.1 
 
 
 
 buffer B). Microsomes were reconstituted
by resuspension in 
 
 
 
250 
 
 
 
l of a solution containing 10–20 
 
 
 
M of purified
hamster BiP (Gaut and Hendershot, 1993) and 200 mM sucrose in buffer B
at pH 9.5. The microsomes were incubated on ice for 5 min, at which time
ATP was added to a final concentration of 5 mM and the pH was then im-
mediately reduced to 7 by the addition of 50 
 
 
 
l of 1.0 M Hepes, pH 6.8.
After a further 5-min incubation on ice, the microsomes were diluted to 1
ml with buffer C and collected by sedimentation (Beckman TLA 100.2 ro-
tor, 60,000 rpm, 20 min, 4
 
 
 
C) through a 200-
 
 
 
l cushion of 0.5 M sucrose
in buffer A. The microsomes were then resuspended in 100 
 
 
 
l buffer C to
yield sealed microsomes reconstituted with rBiP (RRMs). For AMPPNP ex-
periments, the purified BiP protein was preincubated with a 600-fold mo-
lar excess of AMPPNP for 
 
 
 
60 min to replace any bound nucleotide (Wei
and Hendershot, 1995) and no ATP was added before resealing. Where in-
dicated, affinity-purified antibodies against rBiP (Hendershot et al., 1996)
were incubated with purified rBiP protein at neutral pH on ice for 10–20
min before reconstitution as above.
 
Fluorescence spectroscopy
 
Collisional quenching experiments were performed on an SLM-8100 spec-
trofluorimeter in Buffer A at 4
 
 
 
C as described previously (Crowley et al.,
1994; Hamman et al., 1997). Fluorescent (
 
 
 
NBD-Lys-containing) and non-
fluorescent (Lys-containing) samples were prepared and analyzed in paral-
lel in order to subtract scatter and background signals from the measured
intensities of the NBD-containing samples. To introduce large holes into
the ER microsomes, purified PFO protein was added to samples at a final
concentration of 
 
 
 
100 nM and allowed to react for 30 min at room tem-
perature before further fluorescence measurements were made.
Figure 4. Mechanism for maintaining the perme-
ability barrier of the ER membrane during 
cotranslational membrane protein integration. (a) 
Prior to integration, the ribosome-free translocon is 
sealed on the lumenal side by BiP. (b) After SRP-
dependent targeting of a ribosome-nascent chain 
complex to the translocon and translation to yield 
a nascent chain longer than 70 amino acids (Crow-
ley et al., 1994), the ribosome–translocon seal is 
intact and the lumenal end of the pore is open 
(e.g., 111p-86). (c) After the TM sequence has been synthesized and is still near the peptidyltransferase center far inside the ribosome (Liao et 
al., 1997), the lumenal end of the translocon pore is closed by the action of BiP (111p-88, 111p-91). Although BiP is shown here physically 
plugging the pore, BiP may effect closure indirectly by binding to another protein(s) that physically closes the pore. At this point, the ribo-
some–translocon seal is still intact. (d) The ribosome–translocon seal is then broken, whereas the BiP-dependent seal at the other end of the 
pore remains intact (111p-93). Although the ribosome is depicted here as rotating relative to the translocon, the nature and magnitude of this 
structural change is not yet known. (e) After termination of translation, the TM sequence is integrated into the ER membrane. 
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